Company news
Sinovac Biotech, Ltd. news in 2024
Sinovac Biotech, Ltd.'s news releases, calls and decks from 2024, newest first.
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
December 15, 2024
SINOVAC Reports Unaudited First Half of 2024 Financial Results
August 15, 2024
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
April 28, 2024
Sinovac Amends Shareholder Rights Plan
February 20, 2024
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
January 17, 2024